Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2015

ENGlobal Corporation (ENG) to Standardize Subsea Control Technology with Universal Master Control Station

ENGlobal, through its Subsea Controls and Integration (SCI) group, provides advanced process automation design, engineering services and equipment for the effective integration of communication between topside production facilities and subsea devices on offshore drilling rigs around the world. Since 2008, … Continue reading

Posted in ENGlobal Corp. ENG | Leave a comment

Net Element, Inc. (NETE) Subsidiary Upgrades Mobile Point-of-Sale Restaurant Software with More Features

Net Element’s subsidiary Aptito LLC today unveiled version 2.3 of its cloud-based mobile point-of-sale platform (“MPOS”). This all-in-one  restaurant and bar POS software solution helps restaurants reduce payroll costs, increase customer satisfaction, and enhance their efficiency. MPOS version 2.3 keeps … Continue reading

Posted in Net Element Inc. NETE | Leave a comment

Net Element, Inc. (NETE) Takes Center Stage at Noble Financial Conference

At the recent annual Noble Financial Equities Conference in Florida last week – an opportunity for small-cap, micro-cap and OTC companies to make their pitches for institutional investment –Net Element, Inc. (NASDAQ: NETE) stood out as more and more investors … Continue reading

Posted in Net Element Inc. NETE | Leave a comment

ENGlobal, Inc. (ENG) Business Model, Personnel Build Industry Recognition

ENGlobal provides engineering, automation and construction management services primarily for projects within the oil and gas industry. Established in 1985 as a family business with a single project on the drawing board, ENGlobal has become a recognized provider of multi-discipline … Continue reading

Posted in ENGlobal Corp. ENG | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) – Applying Stem Cell Technology toward Drug Rescue and New Generation Drug Toxicity Screening

Believing that better cells lead to better medicine, VistaGen Therapeutics has been applying pluripotent stem cell technology toward drug rescue, predictive toxicology and drug metabolism screening. VistaGen’s activities are guided by the belief that the key to making better cells … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Net Element, Inc. (NETE) Greases the Wheels for an Outstanding Year

It was only a few years ago, in October 2012, that Nasdaq-listed Net Element stepped into the public market and aggressively set out to operate a sustainable, revenue-generating business model built on cutting-edge technologies. In 2013-2014 the company divested its … Continue reading

Posted in Net Element Inc. NETE | Leave a comment

ENGlobal Corp. (ENG) Engineering Sound Development of Energy

The engineering for the development, production and distribution of various energy sources – including those for oil and natural gas – cannot be overlooked. Exploration and discovery is certainly one key component, but developing a well-engineered site that is efficient, … Continue reading

Posted in ENGlobal Corp. ENG | Leave a comment

Net Element, Inc. (NETE) Ahead of the Game as Consumer Experience Continues to Define M-Commerce Success Globally

As detailed recently by Net Element CEO, Oleg Firer, at the Noble Financial Capital Markets 11th Annual Equity Conference (recorded presentation: http://dtn.fm/nete-noble-presentation-2015), the company’s continued success providing mobile payments and value-added transactional services for both domestic and emerging markets is … Continue reading

Posted in Net Element Inc. NETE | Leave a comment

FluoroPharma Medical, Inc. (FPMI) Starts Presentation at Noble Financial’s 10th Annual Equity Conference

FluoroPharma Medical, Inc. (OTC MKTS: FPMI) is a biopharmaceutical company engaged in the development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. The company’s initial focus is the development of breakthrough PET imaging … Continue reading

Posted in Noble Equity Conference | Leave a comment

Can-Fite BioPharma Ltd. (CANF) Starts Presentation at Noble Financial’s 10th Annual Equity Conference

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) is an advanced clinical stage drug development company with a platform technology that is designed to address the treatment of cancer and inflammatory diseases. The company’s CF101 is in Phase II/III trials for the … Continue reading

Posted in Noble Equity Conference | Leave a comment